Detalles de la búsqueda
1.
Meta-analyses of phase 3 randomised controlled trials of third generation aromatase inhibitors versus tamoxifen as first-line endocrine therapy in postmenopausal women with hormone receptor-positive advanced breast cancer.
Eur J Cancer
; 145: 19-28, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33418233
2.
Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies.
NPJ Breast Cancer
; 7(1): 11, 2021 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33579962
3.
First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study.
Breast
; 38: 144-149, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29324303
4.
Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancer.
Eur J Cancer
; 94: 206-215, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29574365
Resultados
1 -
4
de 4
1
Próxima >
>>